608137-32-2

vyvanse

nrp104

lisdexamfetamine dimesylate

Lisdexamfetamine (L-lysine-d-amphetamine) is a prodrug of the psychostimulant d-amphetamine coupled with the essential amino acid L-lysine. It was developed so that the amphetamine psychostimulant is released and activated more slowly as the prodrug molecule is hydrolyzed consequently cleaving off the amino acid-during the first pass through the intestines and/or the liver. Amphetamines target the trace amine-associated receptor 1 (TAAR1). Amphetamine is also believed to exert its effects by binding to the monoamine transporters (the dopamine transporter or DAT) and increasing extracellular levels of the biogenic amines dopamine, norepinephrine (noradrenaline) and serotonin.

InChI=1S/C15H25N3O/c1-12(11-13-7-3-2-4-8-13)18-15(19)14(17)9-5-6-10-16/h2-4,7-8,12,14H,5-6,9-11,16-17H2,1H3,(H,18,19)/t12-,14-/m0/s1

InChIKey=VOBHXZCDAVEXEY-JSGCOSHPSA-N

lisdexamfetamine

obo2:dinto_DB01255

lisdexamfetamine

C[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CCCCN

C15H25N3O

(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide

PubChem Compound:11597698

PharmGKB:PA164748975

National Drug Code Directory:59417-102-10

Wikipedia:http://en.wikipedia.org/wiki/Lisdexamfetamine

ChemSpider:9772458

RxList:http://www.rxlist.com/cgi/generic/vyvanse.htm

PubChem Substance:46505358

Drugs.com:http://www.drugs.com/cdi/lisdexamfetamine.html